DarrkPhoenix: Alright, let's talk specifics about RNA stability and the vaccine's stability in particular. I'm going to go a bit heavy on the chemical biology here, so if you need clarification on things feel free to ask. RNA is composed of sub-units (nucleotides) that consist of one of four bases (guanine, uracil, cytosine, adenine) linked to a sugar (ribose). The ribose portions of these sub-units are then linked together by phosphate groups via the 3' and 5' hydroxyl groups on each ribose, essentially making a polymer of the phospho-ribose sub-units that's used to present a sequence of bases. This sequence of bases is what's used to encode genetic information for protein construction. This is similar to DNA, with the differences of 1) DNA uses deoxyribose instead of ribose (the 2' hydroxyl group is missing) 2) DNA uses the thymine base in place of uracil and 3) DNA is double-stranded while RNA is typically single-stranded in a biological setting.
The challenge working with RNA is that it's inherently a very unstable molecule. The primary mode of degradation is hydrolysis of the phosphoester linkages, either by water (if in an aqueous environment) or self-hydrolysis via the 2'-hydroxy group that's proximal to the phosphate center (this group is positioned to attack the phosphorous center to make a 5-membered ring, which is kinetically high favored). In vivo RNA is not intended to stick around for very long (it gets transcribed, does its business, then enzymes start chewing it up) so this isn't an issue, but for mRNA vaccines that need to be stored for a while this presents a major issue. It should be noted that DNA doesn't have this issue with stability as 1) it's missing the 2'-hydroxyl group needed for self-hydrolysis and 2) the double-stranded structure confers significant stability to hydrolysis via conformational constraint.
Keeping the temperature low is the simplest way of stopping RNA from degrading (lowering the temperature sufficiently makes it so a given chemical reaction can't get over the energy barrier of its transition state). It's interesting to note, however, the less stringent temperature requirements for the Moderna vaccine vs the Pfizer vaccine. Moderna hasn't yet published on the reason for this, but in their press releases they've attributed it to the lipid nanoparticle encapsulation of the mRNA. Both BioNTech (partnered with Pfizer) and Moderna used lipid nanoparticles as an essential part of their vaccines (this was what made the mRNA approach actually viable), but it seems like Moderna's lipid nanoparticle technology is better at stabilizing the RNA. I suspect this is due to their technology either excluding water better from the interior of the nanoparticles, or restricting the conformation of the RNA strand in a way that confers stability to self-hydrolysis, but we'll need to wait for their publications to know for sure.
So that's a very brief background on RNA stability, which brings us to the central topic of what happens if some level of degradation does occur. In such a case the RNA sequence is basically chopped into multiple fragments, so if taken up by a ribosome will only produce a portion of the SARS-CoV-2 spike protein. However, only the portion with the original 5' end of the sequence will be able to do this- this is due to a regulatory mechanism in the ribsomal complex that looks for what's called the 5' untranslated region (5'-UTR), followed by a start codon (a specific 3-base sequence, usually AUG) before it will start translating a piece of mRNA into a protein. So even if the original mRNA degrades into 20+ pieces only one of those will get translated into a starting fragment of the spike protein. Eventually all of the mRNA fragments will be metabolized to the individual nucleotides, which will then get recycled into other RNA strands that our cells are constantly producing and destroying. The incomplete spike protein will ultimately get metabolized as well- there's plenty of cellular machinery dedicated to breaking down proteins and protein fragments that aren't recognized. If enough of a specific spike protein fragment forms it could potentially also trigger an immune response, but it is highly unlikely that a specific fragment will form in high enough amounts for this if it's just due to chemical cleavage at random points along the RNA chain. It should also be noted that mRNA degradation is something that also happens naturally with our own mRNA, so having protein fragments form from such a case is nothing new to our cells.
Also, since your concern seemed to center specifically around cancer, note that this requires modification or damage of a cell's DNA, and as I earlier explained to another poster the mRNA vaccines are not designed to modify DNA, are not designed to even enter the nucleus, and tested to make sure the components don't unintentionally damage DNA. So we're left with a vaccine that has been tested for mutagenicity (and found to not cause any), and for which no plausible mechanism has been proposed by which it may cause DNA damage. Now, if you have a specific mechanism in mind that you're concerned about I'd be happy to discuss it, but if your worry stems solely from RNA being kinda like DNA, and DNA being something you know is somehow related to cancer, and since you don't understand details beyond that that's good enough for you... well, in that case there's not really much else to discuss.
Now, if there are any questions I'd be happy to try to answer them.
thanks for the explanation gonna take a while to process it.
i read that pfizer is working on a vaccine that also works at -20 degrees i bet this ain't the same like the -80 (because like you say instability issues)
hope i can get my hands on the pfizer vaccine i not to keen on getting the old way vaccine with the virus included.